SCHEMBL2236767

SCHEMBL2236767

CC(OC(=O)COCCO[N+](=O)[O-])OC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.45
BCL9 O00512 1/20 0.44
CTNNB1 P35222 1/20 0.44
GAA P10253 1/20 0.40
KMT2A Q03164 2/20 0.39
PTPN7 P35236 1/20 0.39
PTPN12 Q05209 1/20 0.39
PTPN22 Q9Y2R2 1/20 0.39
MAPT P10636 3/20 0.39
MGLL Q99685 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTGS2 P35354 1/20 0.37
ALDH1A1 P00352 4/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2233288 0.90 BCL9 (0.46) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL22364451 0.90 HTR2A (0.46) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL22364373 0.89 HTR2A (0.45) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL12348662 0.87 HTR2A (0.43) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL2235180 0.85 BCL9 (0.48) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL2236108 0.83 BCL9 (0.46) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL17554614 0.83 BCL9 (0.55) BCL9CTNNB1GAAKMT2APTPN7
SCHEMBL2234018 0.83 HTR2A (0.43) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL2235137 0.81 BCL9 (0.56) HTR2ABCL9CTNNB1GAAKMT2A
SCHEMBL2232640 0.80 BCL9 (0.51) HTR2ABCL9CTNNB1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101245-A1 NITRIC OXIDE RELEASING COMPOUNDS FOR THE TREATMENT OF NEUROPATHIC PAIN NICOX S.A. (FR) 2011-08-25 WO disclosed
WO-2011092065-A1 NITRIC OXIDE RELEASING COMPOUNDS FOR THE TREATMENT OF NEUROPHATIC PAIN NICOX S.A. (FR) 2011-08-04 WO disclosed